PACE STUDY: Primary care use of a C-Reactive Protein (CRP) Point of Care Test (POCT) to help target antibiotic prescribing to patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) who are most likely to benefit.

PACE is a study to see if a quick and safe finger prick blood test, measuring C-reactive protein (CRP) levels, can help guide better antibiotic use in patients suffering from an acute exacerbation of their Chronic Obstructive Pulmonary Disease (COPD)People with COPD often experience attacks or periods when their illness gets worse (sometimes referred to as acute exacerbations). Acute exacerbations can be triggered by many things, including infections, and are sometimes treated with antibiotics. But many patients with an exacerbation will not benefit from antibiotics, and taking antibiotics can sometimes result in side effects or cause the bugs that are normally present in our bodies to become resistant to antibiotics.

 Further information can be found on the study website: 

The following practices are taking part in the study:

Holt Medical Practice, Holt

Manor Farm Medical Centre, Swaffham

Mundesley Medical Centre, Mundesley

Nelson Medical Practice, Great Yarmouth

Sheringham Medical Practice, Sheringham

St Stephens Gate Medical Practice, Norwich

Wymondham Medical Centre, Wymondham